KREBS BIOCHEMICALS & INDUSTRIE (KREBSBIO)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 11.46 10.58 14.89 12.98 11.97 12.89 12.86 11.47 6.10 5.48 4.17 7.27
YOY Revenue Growth % -35.63% 6.63% -28.9% 42.75% 4.47% 21.81% -13.67% -11.64% -49.05% -57.48% -67.58% -36.57%
Other Income 0.19 0.04 0.17 0.03 0.21 0.03 0.09 0.25 0.34 0.01 0.01 0.00
Total Income 11.65 10.62 15.06 13.01 12.18 12.92 12.94 11.72 6.44 5.49 4.17 7.28
Total Expenses + 13.24 14.80 14.36 14.82 14.00 14.20 14.18 16.06 14.69 10.82 10.32 10.41
Cost of Materials Consumed 0.31 1.97 0.63 1.03 1.81 0.37 1.03 1.19 -0.10 0.04 0.00 0.00
Employee Benefit Expense 4.51 4.06 4.09 4.44 3.88 4.25 4.39 4.50 3.45 2.75 2.69 2.69
Other Expenses 8.43 8.77 9.65 9.35 8.32 9.58 8.75 10.37 7.49 4.53 4.27 4.28
Operating Profit -1.78 -4.22 0.53 -1.84 -2.03 -1.31 -1.32 -4.59 -8.59 -5.34 -6.15 -3.13
OPM % -15.5% -39.9% 3.5% -14.2% -16.9% -10.2% -10.3% -40% -140.8% -97.4% -147.6% -43%
Profit Before Tax + -6.94 -5.33 -3.57 -4.98 -5.85 -5.17 -5.76 -7.74 -8.25 -5.32 -6.14 -3.13
Tax Expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00
Tax % - - - - - - - - - - - -
Profit After Tax -6.94 -5.33 -3.57 -4.98 -5.85 -5.17 -5.76 -7.74 -8.27 -5.32 -6.14 -3.13
EPS (Basic) -3.07 -2.47 -1.66 -2.31 -2.72 -2.40 -2.67 -3.59 -3.83 -2.47 -2.85 -1.45

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 43.31 50.42 52.13 52.94 53.70 33.41 47.76
YOY Revenue Growth % -14.1% -3.29% -1.52% -1.41% 60.72% -30.04% -
Other Income 0.71 0.45 0.62 7.92 0.62 0.37 0.33
Total Income 44.02 50.87 52.75 60.86 54.32 33.78 48.09
Total Expenses + 70.94 57.99 57.60 99.24 70.95 55.36 55.46
Cost of Materials Consumed 2.49 5.43 15.36 46.18 25.62 19.18 20.99
Employee Benefit Expense 16.60 16.47 15.84 15.30 15.83 15.08 14.94
Other Expenses 36.19 36.08 26.39 37.76 29.50 21.10 19.53
Operating Profit -27.63 -7.57 -5.47 -46.30 -17.25 -21.95 -7.70
OPM % -63.8% -15% -10.5% -87.4% -32.1% -65.7% -16.1%
Profit Before Exceptional -26.92 -19.73 -24.69 -44.53 -28.36 -28.87 -20.12
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.11
Profit Before Tax + -26.92 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01
Tax Expense 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Tax % - - - - - - -
Profit After Tax -26.94 -19.73 -24.69 -44.53 -28.36 -28.87 -20.01
EPS (Basic) -12.49 -9.16 -11.30 -20.81 -14.53 -16.75 -12.83

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 158.78 160.73 158.92 0.00 0.00 0.00 0.00
Property, Plant & Equipment 145.23 149.30 146.47 0.00 0.00 0.00 0.00
Capital Work in Progress 1.24 0.16 2.24 0.00 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.47 0.66 0.84 0.00 0.00 0.00 0.00
Current Assets + 10.26 17.44 16.06 0.00 0.00 0.00 0.00
Inventories 6.03 9.80 11.95 0.00 0.00 0.00 0.00
Trade Receivables 0.05 1.90 0.53 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 0.14 0.14 0.09 0.00 0.00 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 21.56 21.56 21.56 0.00 0.00 0.00 0.00
Other Equity -167.80 -140.78 -121.02 0.00 0.00 0.00 0.00
Non-Current Liabilities 211.75 235.56 225.34 0.00 0.00 0.00 0.00
Current Liabilities 103.53 61.83 49.10 0.00 0.00 0.00 0.00
Total Liabilities 315.27 297.39 274.44 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities -7.89 2.30 -26.49 -17.22 0.00 0.00 0.00
Cash from Investing Activities -4.97 -7.82 -10.87 -22.90 0.00 0.00 0.00
Cash from Financing Activities 12.86 5.56 37.34 39.51 0.00 0.00 0.00
Net Increase/Decrease in Cash 0.00 0.05 -0.01 -0.61 0.00 0.00 0.00